利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

5 条记录 (耗时 0.031 秒)

    Method of inducing memory B cell development and terminal differentiation
    1.
    发明授权
    Method of inducing memory B cell development and terminal differentiation 有权
    诱导记忆B细胞发育和终末分化的方法

    公开(公告)号：US07993919B2

    公开(公告)日：2011-08-09

    申请号：US10579988

    申请日：2004-11-18

    申请人： Warren J. Leonard ,  Peter Lipsky ,  Herbert C. Morse, III ,  Catherine Rachel Ettinger ,  Rosanne Spolski

    发明人： Warren J. Leonard ,  Peter Lipsky ,  Herbert C. Morse, III ,  Catherine Rachel Ettinger ,  Rosanne Spolski

    IPC分类号： C12N5/00 ,  C12N5/071

    CPC分类号： G01N33/5052 ,  A61K35/17 ,  A61K38/20 ,  A61K2035/124 ,  A61K2039/5158 ,  C12N5/0635 ,  C12N2501/052 ,  C12N2501/23 ,  C12N2501/50 ,  C12N2501/52 ,  G01N2333/54

    摘要： A method is disclosed herein for inducing differentiation of a B cell progenitor into a memory B cells and/or a plasma cell. The method includes contacting a population of cells including a mature B cell or a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. In one embodiment, the B cell progenitor is an immature B cell. A method is also disclosed for enhancing an immune response. The method includes contacting a population of cells including a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. The memory B cells arid/or the plasma cell are then introduced into the subject to enhance the immune response. A method is also disclosed for treating a subject with a condition comprising a specific deficiency of at least one of memory B cells and plasma cells. A method is disclosed for identifying an agent with a physiological effect on one or more of a memory B cell and a plasma cell differentiation. A method is also disclosed for identifying agents that inhibit an activity of IL-21.

    摘要翻译： 本文公开了一种用于诱导B细胞祖细胞分化为记忆B细胞和/或浆细胞的方法。 该方法包括使包含成熟B细胞或B细胞祖细胞的细胞群与有效量的IL-21接触，并分离记忆B细胞或浆细胞。 在一个实施方案中，B细胞祖细胞是未成熟B细胞。 还公开了一种用于增强免疫应答的方法。 该方法包括使包含B细胞祖细胞的细胞群与有效量的IL-21接触，并分离记忆B细胞或浆细胞。 然后将记忆B细胞和/或浆细胞引入受试者以增强免疫应答。 还公开了一种用于治疗患有包含存储B细胞和浆细胞中的至少一种的特定缺陷的病症的受试者的方法。 公开了用于鉴定对存储B细胞和浆细胞分化中的一种或多种具有生理作用的药剂的方法。 还公开了用于鉴定抑制IL-21活性的试剂的方法。

    METHOD OF INDUCING MEMORY B CELL DEVELOPMENT AND TERMINAL DIFFERENTIATION
    3.
    发明申请
    METHOD OF INDUCING MEMORY B CELL DEVELOPMENT AND TERMINAL DIFFERENTIATION 有权
    诱导记忆B细胞发育和终末分化的方法

    公开(公告)号：US20080305076A1

    公开(公告)日：2008-12-11

    申请号：US12126166

    申请日：2008-05-23

    申请人： Catherine Rachel Ettinger ,  Peter E. Lipsky ,  Warren J. Leonard ,  Rosanne Spolski ,  Herbert C. Morse, III

    发明人： Catherine Rachel Ettinger ,  Peter E. Lipsky ,  Warren J. Leonard ,  Rosanne Spolski ,  Herbert C. Morse, III

    IPC分类号： A61K38/20 ,  C12Q1/02 ,  C40B30/06 ,  A61K48/00 ,  A61K31/711 ,  G01N33/567 ,  C12N5/06

    CPC分类号： G01N33/5052 ,  A61K35/17 ,  A61K38/20 ,  A61K2035/124 ,  A61K2039/5158 ,  C12N5/0635 ,  C12N2501/052 ,  C12N2501/23 ,  C12N2501/50 ,  C12N2501/52 ,  G01N2333/54

    摘要： A method is disclosed herein for inducing differentiation of a B cell progenitor into a memory B cells and/or a plasma cell. The method includes contacting a population of cells including a mature B cell or a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. In one embodiment, the B cell progenitor is an immature B cell. A method is also disclosed for enhancing an immune response. The method includes contacting a population of cells including a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. The memory B cells and/or the plasma cell are then introduced into the subject to enhance the immune response. A method is also disclosed for treating a subject with a condition comprising a specific deficiency of at least one of memory B cells and plasma cells. A method is disclosed for identifying an agent with a physiological effect on one or more of a memory B cell and a plasma cell differentiation. A method is also disclosed for identifying agents that inhibit an activity of IL-21. Methods are also disclosed for inducing apoptosis of a B cell and for decreasing the number of B cells. A method is also described for producing a B cell hybridoma.

    摘要翻译： 本文公开了一种用于诱导B细胞祖细胞分化为记忆B细胞和/或浆细胞的方法。 该方法包括使包含成熟B细胞或B细胞祖细胞的细胞群与有效量的IL-21接触，并分离记忆B细胞或浆细胞。 在一个实施方案中，B细胞祖细胞是未成熟B细胞。 还公开了一种用于增强免疫应答的方法。 该方法包括使包含B细胞祖细胞的细胞群与有效量的IL-21接触，并分离记忆B细胞或浆细胞。 然后将记忆B细胞和/或浆细胞引入受试者以增强免疫应答。 还公开了一种用于治疗患有包含存储B细胞和浆细胞中的至少一种的特定缺陷的病症的受试者的方法。 公开了用于鉴定对存储B细胞和浆细胞分化中的一种或多种具有生理作用的药剂的方法。 还公开了用于鉴定抑制IL-21活性的试剂的方法。 还公开了诱导B细胞凋亡和减少B细胞数量的方法。 还描述了用于产生B细胞杂交瘤的方法。

    Method of inducing memory B cell development and terminal differentiation
    4.
    发明授权
    Method of inducing memory B cell development and terminal differentiation 有权
    诱导记忆B细胞发育和终末分化的方法

    公开(公告)号：US07378276B2

    公开(公告)日：2008-05-27

    申请号：US11197221

    申请日：2005-08-03

    申请人： Catherine Rachel Ettinger ,  Peter E. Lipsky ,  Warren J. Leonard ,  Rosanne Spolski ,  Herbert C. Morse, III

    发明人： Catherine Rachel Ettinger ,  Peter E. Lipsky ,  Warren J. Leonard ,  Rosanne Spolski ,  Herbert C. Morse, III

    IPC分类号： C12N5/02 ,  C12N5/08 ,  A01N37/18 ,  C07K1/00

    CPC分类号： G01N33/5052 ,  A61K35/17 ,  A61K38/20 ,  A61K2035/124 ,  A61K2039/5158 ,  C12N5/0635 ,  C12N2501/052 ,  C12N2501/23 ,  C12N2501/50 ,  C12N2501/52 ,  G01N2333/54

    摘要： A method is disclosed herein for inducing differentiation of a B cell progenitor into a memory B cells and/or a plasma cell. The method includes contacting a population of cells including a mature B cell or a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. In one embodiment, the B cell progenitor is an immature B cell. A method is also disclosed for enhancing an immune response. The method includes contacting a population of cells including a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. The memory B cells and/or the plasma cell are then introduced into the subject to enhance the immune response. A method is also disclosed for treating a subject with a condition comprising a specific deficiency of at least one of memory B cells and plasma cells. A method is disclosed for identifying an agent with a physiological effect on one or more of a memory B cell and a plasma cell differentiation. A method is also disclosed for identifying agents that inhibit an activity of IL-21. Methods are also disclosed for inducing apoptosis of a B cell and for decreasing the number of B cells. A method is also described for producing a B cell hybridoma.

    摘要翻译： 本文公开了一种用于诱导B细胞祖细胞分化为记忆B细胞和/或浆细胞的方法。 该方法包括使包含成熟B细胞或B细胞祖细胞的细胞群与有效量的IL-21接触，并分离记忆B细胞或浆细胞。 在一个实施方案中，B细胞祖细胞是未成熟的B细胞。 还公开了一种用于增强免疫应答的方法。 该方法包括使包含B细胞祖细胞的细胞群与有效量的IL-21接触，并分离记忆B细胞或浆细胞。 然后将记忆B细胞和/或浆细胞引入受试者以增强免疫应答。 还公开了一种用于治疗患有包含存储B细胞和浆细胞中的至少一种的特定缺陷的病症的受试者的方法。 公开了用于鉴定对存储B细胞和浆细胞分化中的一种或多种具有生理作用的药剂的方法。 还公开了用于鉴定抑制IL-21活性的试剂的方法。 还公开了诱导B细胞凋亡和减少B细胞数量的方法。 还描述了用于产生B细胞杂交瘤的方法。

    Brother of the regulator of imprinted sites (BORIS)
    5.
    发明授权
    Brother of the regulator of imprinted sites (BORIS) 有权
    兄弟的压印网站监管机构（BORIS）

    公开(公告)号：US07375206B2

    公开(公告)日：2008-05-20

    申请号：US10505377

    申请日：2003-02-21

    申请人： Victor V. Lobanenkov ,  Dmitri I. Loukinov ,  Herbert C. Morse, III

    发明人： Victor V. Lobanenkov ,  Dmitri I. Loukinov ,  Herbert C. Morse, III

    IPC分类号： C07H21/04 ,  C07H21/02 ,  C12Q1/68

    CPC分类号： C07K14/47 ,  C07K14/4702 ,  C12Q1/6886 ,  C12Q2600/106 ,  G01N33/57484

    摘要： An isolated or purified nucleic acid molecule consisting essentially of a nucleotide sequence encoding a human or a non-human BORIS, or a fragment of either of the foregoing; an isolated or purified nucleic acid molecule consisting essentially of a nucleotide sequence that is complementary to a nucleotide sequence encoding a human or a non-human BORIS, or a fragment of either of the foregoing; a vector comprising such an isolated or purified nucleic acid molecule; a cell comprising such a vector; an isolated or purified polypeptide molecule consisting essentially of an amino acid sequence encoding a human or a non-human BORIS, or a fragment of either of the foregoing; a cell line that produces a monoclonal antibody that is specific for an aforementioned isolated or purified polypeptide molecule; and the monoclonal antibody produced by the cell line; methods of diagnosing a cancer or a predisposition to a cancer in a male or female mammal; a method of prognosticating a cancer in a mammal; a method of assessing the effectiveness of treatment of a cancer in a mammal; a method of treating a mammal prophylactically or therapeutically for a cancer, and a composition comprising a carrier and an inhibitor of BORIS.

    摘要翻译： 分离或纯化的核酸分子，主要由编码人或非人BORIS的核苷酸序列或前述任一种的片段组成; 基本上由与编码人或非人BORIS的核苷酸序列互补的核苷酸序列或前述任一种的片段组成的分离或纯化的核酸分子; 包含这种分离或纯化的核酸分子的载体; 包含这种载体的细胞; 基本上由编码人或非人BORIS的氨基酸序列或前述任一种的片段组成的分离或纯化的多肽分子; 产生对上述分离或纯化的多肽分子特异性的单克隆抗体的细胞系; 和由细胞系产生的单克隆抗体; 在男性或女性哺乳动物中诊断癌症或倾向于癌症的方法; 预测哺乳动物癌症的方法; 一种评估哺乳动物癌症治疗有效性的方法; 用于预防或治疗癌症的哺乳动物的方法，以及包含载体和BORIS抑制剂的组合物。